IP Library Granted Patent US 9,180,079
Granted Patent B2
US 9,180,079 · App. 13/978,036 · Granted Nov 10, 2015

Skin external preparation and method of producing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,180,079
App. No.
13/978,036
Granted
Nov 10, 2015
Kind
B2
Abstract

A skin external preparation containing an ascorbic acid-2-phosphate derivative is characterized in that only a sodium ascorbic acid-2-phosphate-6-palmitate is formulated as the ascorbic acid-2-phosphate derivative, and the skin preparation further includes at least one betaine-type amphoteric surfactant selected from the group consisting of compounds represented by the following general formula (1) or (2) (wherein R 1 represents a linear or branched alkyl group of 6 to 30 carbon atoms, and R 2 represents a linear or branched alkyl group of 8 to 30 carbon atoms). R 1 —N + (CH 3 ) 2 —CH 2 COO −   (1) R 2 —CONH—CH 2 —CH 2 —CH 2 —N + (CH 3 ) 2 —CH 2 COO −   (2)

Claims (19)

1. A skin external preparation comprising an ascorbic acid-2-phosphate derivative, characterized in that

only a sodium ascorbic acid-2-phosphate-6-palmitate is formulated as the ascorbic acid-2-phosphate derivative, and

the skin external preparation further comprises at least one betaine-type amphoteric surfactant selected from the group consisting of compounds represented by a general formula (1) or (2) shown below:

R 1 —N + (CH 3 ) 2 —CH 2 COO −   (1)

R 2 —CONH—CH 2 —CH 2 —CH 2 —N + (CH 3 ) 2 —CH 2 COO −   (2)

wherein R 1 represents a linear or branched alkyl group of 10 to 30 carbon atoms, and R 2 represents a linear or branched alkyl group of 8 to 30 carbon atoms.

2. The skin external preparation according to claim 1 , wherein at least one of the betaine-type amphoteric surfactantis a compound of the general formula (1) in which R 1 is a linear or branched alkyl group of 12 to 24 carbon atoms.

3. The skin external preparation according to claim 1 , wherein at least one of the betaine-type amphoteric surfactantis a compound of the general formula (2) in which R 2 is a linear or branched alkyl group of 12 to 24 carbon atoms.

4. The skin external preparation according to claim 1 , wherein a formulating amount of the sodium ascorbic acid-2-phosphate-6-palmitate is within a range from 0.01 to 10% by mass, relative to a total mass of the skin external preparation.

5. The skin external preparation according to claim 1 , wherein an amount of the betaine-type amphoteric surfactant is within a range from 0.1 to 10% by mass, relative to a total mass of the skin external preparation.

6. The skin external preparation according to claim 1 , wherein a pH of the skin external preparation is within a range from 6.5 to 7.5.

7. The skin external preparation according to claim 1 , wherein the skin external preparation is a cosmetic material.

8. A method of producing a skin external preparation comprising an ascorbic acid-2-phosphate derivative, the method comprising:

formulating: only a sodium ascorbic acid-2-phosphate-6-palmitate as the ascorbic acid-2-phosphate derivative; and at least one betaine-type amphoteric surfactant selected from the group consisting of compounds represented by a general formula (1) or (2) shown below:

R 1 —N + (CH 3 ) 2 —CH 2 COO −   (1)

R 2 —CONH—CH 2 —CH 2 —CH 2 —N + (CH 3 ) 2 —CH 2 COO −   (2)

wherein R 1 represents a linear or branched alkyl group of 10 to 30 carbon atoms, and R 2 represents a linear or branched alkyl group of 8 to 30 carbon atoms.

9. The method according to claim 8 , wherein the sodium ascorbic acid-2-phosphate-6-palmitate is formulated in an amount of 0.01 to 10% by mass, relative to a total mass of the skin external preparation.

10. The method according to claim 8 , wherein the betaine-type amphoteric surfactant is formulated in an amount of 0.1 to 10% by mass, relative to a total mass of the skin external preparation.

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 14, 2024
From: RESONAC CORPORATION
To: RESONAC CORPORATION
Reel/Frame 066599/0037 →
CHANGE OF NAME Recorded Jun 23, 2023
From: SHOWA DENKO K.K.
To: RESONAC CORPORATION
Reel/Frame 064082/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2013
From: ITO, NAOKO
To: SHOWA DENKO K.K.
Reel/Frame 030737/0400 →